Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Critical Care Medicine|July 14, 2021
Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane OxygenationNina Buchtele, Michael Schwameis, Peter Schellongowski, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel diseaseJulia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2018
Dynamic reference intervals for coagulation parameters from infancy to adolescenceChristina Weidhofer, Elias Meyer, Robin Ristl, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Argatroban in Patients with Extracorporeal Membrane Oxygenation-A Randomized Controlled Pilot TrialNina Buchtele, Bernhard Nagler, Peter Schellongowski, et al.
Platelets|August 9, 2020
Immature cell fractions after cessation of chronic P2Y<sub>12</sub>-inhibition in patients with coronary artery diseasesBernhard Jäger, Kris G Vargas, Paul M Haller, et al.
Vox Sanguinis|April 26, 2006
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)Peter Schellongowski, Edith Bauer, Ulrike Holzinger, et al.
Clinical Chemistry and Laboratory Medicine|October 27, 2012
Interference of the new oral anticoagulant dabigatran with frequently used coagulation testsWalter-Michael Halbmayer, Guenter Weigel, Peter Quehenberger, et al.
Transfusion|January 17, 2013
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
Thrombosis Research|October 8, 2021
Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopeniaJohannes Thaler, Petra Jilma, Nazanin Samadi, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Critical Care Medicine|July 14, 2021
Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane OxygenationNina Buchtele, Michael Schwameis, Peter Schellongowski, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel diseaseJulia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2018
Dynamic reference intervals for coagulation parameters from infancy to adolescenceChristina Weidhofer, Elias Meyer, Robin Ristl, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Argatroban in Patients with Extracorporeal Membrane Oxygenation-A Randomized Controlled Pilot TrialNina Buchtele, Bernhard Nagler, Peter Schellongowski, et al.
Platelets|August 9, 2020
Immature cell fractions after cessation of chronic P2Y<sub>12</sub>-inhibition in patients with coronary artery diseasesBernhard Jäger, Kris G Vargas, Paul M Haller, et al.
Vox Sanguinis|April 26, 2006
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)Peter Schellongowski, Edith Bauer, Ulrike Holzinger, et al.
Clinical Chemistry and Laboratory Medicine|October 27, 2012
Interference of the new oral anticoagulant dabigatran with frequently used coagulation testsWalter-Michael Halbmayer, Guenter Weigel, Peter Quehenberger, et al.
Transfusion|January 17, 2013
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
Thrombosis Research|October 8, 2021
Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopeniaJohannes Thaler, Petra Jilma, Nazanin Samadi, et al.
Pageof 14